After U.S. President Donald Trump advocated widespread use of two malaria drugs for COVID-19 patients, the FDA, led by Commissioner Stephen Hahn (left) produced an emergency use authorization for the medications.
By Charles PillerScience’s COVID-19 reporting is supported by the Pulitzer Center.The recent Food and Drug Administration (FDA) emergency use authorization (EUA) for two malaria drugs to treat COVID-19, based on thin evidence of efficacy, has jeopardized research to learn the drugs’ real value against the pandemic coronavirus, say former agency executives under President Donald Trump and former President Barack Obama.